Interleukin-33-mediated signaling pathway

pathway activity — cross-omics
GO:0038172Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Interleukin-33-mediated signaling pathway pathway is significantly associated with the RNA expression of multiple genes, with the BLOOD_Lymphoma cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SELENOW, UHMK1, and ZNF264, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Interleukin-33-mediated signaling pathway activity versus SELENOW in BLOOD_Lymphoma (Pearson r = 0.53).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LymphomaSELENOW →+3.731+0.430<.001.00234
CNSUHMK1 →+0.993+0.648.001.00225
CNSZNF264 →+0.941+0.534.001.00434
CNSARAP2 →+1.351+0.671<.001<.00133
SKINSPTBN2 →-2.050-0.523<.001.00833
OVARYECSCR →+6.125+0.564.006.00833
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0038172 vs SELENOW — BLOOD_Lymphoma

Per-sample scatter of Interleukin-33-mediated signaling pathway activity vs SELENOW in BLOOD_Lymphoma.

Explore this scatter interactively →

Exploration